News
A University of Pennsylvania biotechnology company that aims to treat autoimmune diseases by reengineering cells within the ...
17h
The Times of Israel on MSNZelig Eshhar, leading cancer researcher and immunologist, dies at 84Research by Weizmann Institute scientist and Israel Prize winner saved 'countless lives,' was basis for technology sold for ...
A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...
While data is promising, many questions remain about topics such as timing and doses in the treatment of hematologic malignancies.
A team of physicians recently reported the successful treatment of refractory autoimmune neuropathies through the infusion of ...
1d
News Medical on MSNStudy unveils powerful strategy to rejuvenate effectiveness of CAR T cell therapy against glioblastomaA team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and ...
Chimeric antigen receptors combine an antigen-recognition domain of a specific antibody with an intracellular domain of the CD3-zeta chain or FcγRI protein into a single chimeric protein. 1,2 ...
During a live event, Priyanka Pophali, MD, MBBS, discussed CAR T-cell therapy referrals, timing, and challenges in relapsed ...
2d
News-Medical.Net on MSNLeukemia-on-a-chip offers breakthrough in personalized cancer treatmentA team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...
chimeric antigen receptor 1 Articles . CRISPR Could Fry All Cancer Using Newly Found T-Cell. January 27, 2020 by Kristina Panos 36 Comments . One of the human body’s greatest features is its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results